You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

41 Results
Guidelines and Advice
Drug
Other Name(s): Leukeran®
Nov 2024
Drug
Nov 2024
Drug
Other Name(s): BiCNU®
Oct 2022
Drug
Other Name(s): Leustatin®
Nov 2024
Drug
Other Name(s): Jevtana®
Nov 2024
Drug
Other Name(s): Xalkori®
Jan 2022
Drug
Other Name(s): Zykadia™
Nov 2024
Drug
Other Name(s): Cotellic™
Nov 2024
Regimen
Intent: Neoadjuvant, Adjuvant
Funding:
New Drug Funding Program
    Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer
Feb 2022
Regimen
Cancer Type:
Genitourinary, 
Prostate
Intent: Palliative
Funding:
New Drug Funding Program
    Cabazitaxel - Metastatic Castration Resistant Prostate Cancer
ODB - General Benefit
    prednisone
Nov 2024
Regimen
Cancer Type:
Gynecologic, 
Ovary
Intent: Palliative
Funding:
New Drug Funding Program
    Liposomal Doxorubicin with Carboplatin - Platinum-Sensitive Recurrent Ovarian Fallopian Tube and Primary Peritoneal Cancer
Jun 2022

Pages